This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n10http://id.nlm.nih.gov/mesh/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
dbpediahttp://dbpedia.org/resource/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q5452194
rdf:type
wikibase:Item
owl:sameAs
dbpedia:First-in-man_study
schema:description
健常人を対象に被験薬の安全性や薬物動態を検討する、治験の段階 phase of a clinical trial studying safety and dosage počáteční fáze klinického hodnocení nového léku fase más temprana de un ensayo clínico, dirigida a estudiar la seguridad y dosis
rdfs:label
faza I kliničnega preskušanja 第I相試験 klinische proeffase I fase 1 d'assaig clínic Ⅰ期临床试验 phase I clinical trial fase 1 de ensayo clínico Ⅰ期临床试验 фаза I клиничког тестирања Phase-I-Studie essai clinique phase 1 studie I. fáze
skos:prefLabel
essai clinique phase 1 Ⅰ期临床试验 faza I kliničnega preskušanja phase I clinical trial fase 1 d'assaig clínic klinische proeffase I 第I相試験 фаза I клиничког тестирања Phase-I-Studie fase 1 de ensayo clínico Ⅰ期临床试验 studie I. fáze
schema:name
Ⅰ期临床试验 fase 1 de ensayo clínico фаза I клиничког тестирања 第I相試験 faza I kliničnega preskušanja studie I. fáze fase 1 d'assaig clínic Ⅰ期临床试验 essai clinique phase 1 klinische proeffase I phase I clinical trial Phase-I-Studie
p:P155
wds:Q5452194-BEDAAEF6-FF9E-47CA-8032-3E641C979144
p:P156
wds:Q5452194-9F1F52A0-FAE3-4998-ABEE-8AE128E77F40
p:P31
wds:Q5452194-3F797220-9C34-4561-8592-0B7F1C0D1A54
p:P361
wds:Q5452194-677DD302-41ED-4377-BE02-3B15A898C1DB wds:Q5452194-7A88D121-F413-4F6D-8F60-C51458F06683
wdt:P155
wd:Q7239206
wdt:P156
wd:Q42824440
wdt:P31
wd:Q7180990
wdt:P361
wd:Q7180990 wd:Q1550789
p:P279
wds:Q5452194-F7A11767-54AB-4E56-8B22-3C7B1AF07349
wdt:P279
wd:Q30612
p:P527
wds:Q5452194-30D472ED-AF80-4184-9BB4-61B65F953C0A
wdt:P527
wd:Q5299247
p:P710
wds:Q5452194-E2A8602F-01D8-4FF2-A403-6F0793F178A6 wds:Q5452194-62FA67AD-A7B9-40A6-8B4C-57CAB25F3780 wds:Q5452194-D1C084F0-F6B2-480D-A2A0-6DFC7E2D446A
wdt:P710
wd:Q4204239 wd:Q15401884 wd:Q181600
skos:altLabel
studie fáze I Clinical Trial, Phase I 第1相試験 phase I phase 1 1. fáze klinického hodnocení Phase-1-Studie Klinik Phase 1 phase 1 trial Klinik Phase I フェーズ1 フェーズI 1. faza kliničnega preskušanja I. faza kliničnega preskušanja primera fase de ensayo clínico First-in-man study phase I trial phase 1 clinical trial fáze I klinického hodnocení
p:P10565
wds:Q5452194-F97FAB6C-2817-4AB7-9D7A-1BA1D77E0815
p:P3827
wds:Q5452194-BACCCE2B-0CF5-4005-92BD-530E9EF14EE7
p:P486
wds:Q5452194-0AA53452-C2E5-41D5-B516-0ED8811D550D wds:Q5452194-C5BC2F8F-8B54-401B-9F85-8EBC662C9AC0
p:P5008
wds:Q5452194-BD683C79-5769-4130-B1AB-E20DD3A9A176
p:P672
wds:Q5452194-A333C8D6-AB31-4298-83AC-A793C1F00443 wds:Q5452194-935A7C30-3BA2-4F4C-A762-AAD2DBDE8774 wds:Q5452194-4D0DB9C3-8BF6-4BC7-BE79-4FE8B2F98579 wds:Q5452194-7E5D00DC-BDFF-48FE-BF52-AC87A29A30EC
wdtn:P486
n10:D017321 n10:D017426
wdtn:P672
n10:N06.850.520.450.250.250.200 n10:V03.175.250.100 n10:E05.318.372.250.250.200 n10:N05.715.360.330.250.250.200
wdt:P10565
296039
wdt:P3827
phase-i-clinical-trials
wdt:P486
D017321 D017426
wdt:P5008
wd:Q54439832
wdt:P672
N06.850.520.450.250.250.200 N05.715.360.330.250.250.200 E05.318.372.250.250.200 V03.175.250.100
p:P4967
wds:Q5452194-7640908D-3A18-4826-A7FA-244114803B71
wdt:P4967
wd:Q6060674
p:P3712
wds:Q5452194-E5EBB947-7AD8-4D9E-B1EE-823E193ED68D wds:Q5452194-EFE765ED-99DE-4B35-933D-C58B06A865CB
wdt:P3712
wd:Q42240